CINCINNATI--(BUSINESS WIRE)--CinFina Pharma, a CinRx portfolio company dedicated to advancing a portfolio of high-impact treatment options for obesity, will present two posters at ObesityWeek ...

About CIN-109: CIN-109 is a Phase 2 ready, a novel, long-acting, first-in-class growth differentiation factor 15 (GDF-15) analog for the treatment of obesity. CIN-109 is a Phase 2 ready candidate ...

CinFina Pharma, a CinRx portfolio company dedicated to advancing a portfolio of high-impact treatment options for obesity, will present two posters at ObesityWeek® 2024, held at the Henry B. Gonzalez ...

Released on Deol's birthday, the first-look poster showcases him in a fierce avatar. Scheduled for a potential Republic Day 2025 release, 'Jaat' might clash with Akshay Kumar's 'Sky Force.' ...

Overweight and obesity both describe conditions of excessive body fat that presents a risk to health. 2 Excessive fat deposits increase our risk of type 2 diabetes, heart disease, certain cancers, and ...

According to the CDC, as of August 2023, 40.3 percent of U.S. adults—some 100 million people—met the clinical definition for obesity. But this same estimate, which is based on National Health ...

List of countries by obesity rate: Overweight and obesity, resulting from excessive fat accumulation, have become significant health concerns today, with global adult obesity having more than doubled ...

From the announcement of the film to till date, the buzz on 'Pushpa 2: The Rule' is very high and here are the times when the makers of the film launched powerful posters! The makers on October 17 ...

New data released by the Centers for Disease Control and Prevention (CDC) has provided insight into the prevalence of obesity across the United States. The figures, initially from the 2023 Adult ...

Obesity is a multifactorial, chronic, relapsing, non-communicable disease marked by an abnormal and/or excessive accumulation of body fat that presents a risk to health. It is well established that ...